Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of Short-Term Single AntiPlatelet Therapy After Left Atrial Appendage Closure With the LAmbre Device in Patients With Nonvalvular Atrial Fibrillation: A Multinational Real-world Registry

NCT06620757 is registered in ClinicalTrials.gov with Fundación EPIC as lead sponsor.

NCT NCT06620757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06620757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of Short-Term Single AntiPlatelet Therapy After Left Atrial Appendage Closure With the LAmbre Device in Patients With Nonvalvular Atrial Fibrillation: A Multinational Real-world Registry
Lead sponsor
Fundación EPIC
Phase
Observational
Overall status
Recruiting
Start date
October 10, 2024
Completion date
October 20, 2027
Enrollment
234 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation